Cytokeratin 19 antibody (AA 1-400)
Quick Overview for Cytokeratin 19 antibody (AA 1-400) (ABIN5776025)
Target
See all Cytokeratin 19 (KRT19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-400
-
Purpose
- Human Cytokeratin 19 antibody
-
Purification
- Purified
-
Immunogen
- Recombinant human KRT19 (1-400aa) purified from E. coli
-
Isotype
- IgG2b kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Alternative Name
- Cytokeratin 19
-
Background
- KRT19 (type 1 cytokeratin 19) is 44 kDa intermediate filament (IF) protein that is part of the Keratin family of proteins. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells and have been found to be useful markers of tissue differentiation. KRT19 is an important biomarker for breast cancer cells, tumor cells of the lymph nodes, peripheral blood, and bone marrow. Cytokeratin 19 can be expressed with KRT8 and KRT18 to differentiate cells of epithelial lines from hematopoietic tumor cells in the peripheral blood.
-
NCBI Accession
- NP_002267
Target
-